Literature DB >> 22079939

Long-term recovery of β-cell function after partial pancreatectomy in humans.

Bjoern A Menge1, Thomas G K Breuer, Peter R Ritter, Waldemar Uhl, Wolfgang E Schmidt, Juris J Meier.   

Abstract

Glucose homeostasis is significantly altered immediately after partial pancreatectomy. The present study examined the long-term consequences of a hemipancreatectomy in 10 patients with chronic pancreatitis and 10 patients with benign pancreatic and extrapancreatic tumors. A 240-minute oral glucose challenge was performed before and shortly after pancreatic surgery, as well as after a follow-up of 3.1 ± 0.5 years. Plasma concentrations of glucose, insulin, and C-peptide were determined; and indices of insulin sensitivity and insulin secretion were calculated. In both groups of patients, fasting and postchallenge glucose concentrations were significantly altered immediately after surgery, but returned to preoperative levels at the time of follow-up (P < .0001). Postchallenge insulin and C-peptide concentrations were reduced immediately after surgery (P < .0001), but were partly normalized at the time of follow-up (P < .0001). These changes were not accompanied by improvements in insulin sensitivity (Matsuda index). However, the oral disposition index revealed a significant recovery of β-cell function at the time of follow-up (P < .05). These findings demonstrate a capacity for recovery of glucose control after partial pancreatectomy and suggest that β-cell function can improve significantly over time even in adult humans.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22079939     DOI: 10.1016/j.metabol.2011.09.019

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  9 in total

1.  Mig6 haploinsufficiency protects mice against streptozotocin-induced diabetes.

Authors:  Yi-Chun Chen; E Scott Colvin; Katherine E Griffin; Bernhard F Maier; Patrick T Fueger
Journal:  Diabetologia       Date:  2014-07-04       Impact factor: 10.122

2.  Mouse Pancreas Stem/Progenitor Cells Get Augmented by Streptozotocin and Regenerate Diabetic Pancreas After Partial Pancreatectomy.

Authors:  Subhan Ali Mohammad; Siddhanath Metkari; Deepa Bhartiya
Journal:  Stem Cell Rev Rep       Date:  2020-02       Impact factor: 5.739

Review 3.  Stem cells versus plasticity in liver and pancreas regeneration.

Authors:  Janel L Kopp; Markus Grompe; Maike Sander
Journal:  Nat Cell Biol       Date:  2016-03       Impact factor: 28.824

Review 4.  The Impact of Pancreatic Exocrine Diseases on the β-Cell and Glucose Metabolism-A Review with Currently Available Evidence.

Authors:  Marina Ciochina; Daniel Vasile Balaban; George Manucu; Mariana Jinga; Cristian Gheorghe
Journal:  Biomolecules       Date:  2022-04-21

Review 5.  Stress-induced adaptive islet cell identity changes.

Authors:  V Cigliola; F Thorel; S Chera; P L Herrera
Journal:  Diabetes Obes Metab       Date:  2016-09       Impact factor: 6.577

Review 6.  The regulation of pre- and post-maturational plasticity of mammalian islet cell mass.

Authors:  Teresa Mezza; Rohit N Kulkarni
Journal:  Diabetologia       Date:  2014-05-14       Impact factor: 10.122

7.  Very small embryonic-like stem cells are involved in regeneration of mouse pancreas post-pancreatectomy.

Authors:  Deepa Bhartiya; Akash Mundekar; Vaibhav Mahale; Hiren Patel
Journal:  Stem Cell Res Ther       Date:  2014-09-02       Impact factor: 6.832

8.  Blood Glucose Homeostasis in the Course of Partial Pancreatectomy--Evidence for Surgically Reversible Diabetes Induced by Cholestasis.

Authors:  Florian Ehehalt; Dorothée Sturm; Manuela Rösler; Marius Distler; Jürgen Weitz; Stephan Kersting; Barbara Ludwig; Uta Schwanebeck; Hans-Detlev Saeger; Michele Solimena; Robert Grützmann
Journal:  PLoS One       Date:  2015-08-06       Impact factor: 3.240

Review 9.  The Cells of the Islets of Langerhans.

Authors:  Gabriela Da Silva Xavier
Journal:  J Clin Med       Date:  2018-03-12       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.